• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保留皮肤乳房切除术后导管原位癌的局部复发

Local recurrence of ductal carcinoma in situ after skin-sparing mastectomy.

作者信息

Carlson Grant W, Page Andrew, Johnson Earl, Nicholson Kimberly, Styblo Toncred M, Wood William C

机构信息

Department of Surgery, Emory University School of Medicine, Atlanta GA, USA.

出版信息

J Am Coll Surg. 2007 May;204(5):1074-8; discussion 1078-80. doi: 10.1016/j.jamcollsurg.2007.01.063.

DOI:10.1016/j.jamcollsurg.2007.01.063
PMID:17481544
Abstract

BACKGROUND

The incidence of local recurrence (LR) after conventional total mastectomy for ductal carcinoma in situ (DCIS) ranges from 1% to 3%. Skin-sparing mastectomy (SSM) preserves the native skin envelope to facilitate immediate breast reconstruction. Because DCIS is generally not clinically apparent, there is a potential for inadequate excision when SSM is performed. Risk factors for local recurrence after SSM for DCIS are examined.

STUDY DESIGN

A retrospective review of 223 consecutive patients with DCIS treated by SSM and immediate reconstruction was performed. Age younger than 50 years, tumor size > 40 mm, high tumor grade, tumor necrosis, surgical margins < 1 mm, type of biopsy (excisional versus core), and SSM type were examined as risk factors for recurrence.

RESULTS

Mean followup was 82.3 months (range 4.9 to 123.2 months). Recurrences developed in 11 patients (5.1%), including: local (n = 7; 3.3%), regional (n = 2; 0.9%), and distant (n = 2; 0.9%). All seven local recurrences were detected by physical examination. No patients received adjuvant radiation therapy. Two of 19 patients with surgical margins < 1 mm developed LR (10.5%). Univariate analysis showed high tumor grade (p = .019) to influence LR.

CONCLUSIONS

The incidence of local recurrence of DCIS after SSM is similar to conventional total mastectomy. Reexcision of close margins should be performed if possible and adjuvant radiation therapy should be considered.

摘要

背景

导管原位癌(DCIS)行传统全乳切除术后局部复发(LR)的发生率为1%至3%。保乳手术(SSM)保留了天然皮肤包膜,便于即刻乳房重建。由于DCIS通常在临床上不明显,因此在进行SSM时存在切除不充分的可能性。本研究对DCIS行SSM术后局部复发的危险因素进行了分析。

研究设计

对223例连续接受SSM及即刻乳房重建的DCIS患者进行回顾性分析。将年龄小于50岁、肿瘤大小>40mm、肿瘤分级高、肿瘤坏死、手术切缘<1mm、活检类型(切除活检与粗针活检)及SSM类型作为复发的危险因素进行分析。

结果

平均随访82.3个月(范围4.9至123.2个月)。11例(5.1%)患者出现复发,包括:局部复发(n=7;3.3%)、区域复发(n=2;0.9%)和远处复发(n=2;0.9%)。所有7例局部复发均通过体格检查发现。无一例患者接受辅助放疗。19例手术切缘<1mm的患者中有2例出现局部复发(10.5%)。单因素分析显示肿瘤分级高(p=0.019)会影响局部复发。

结论

DCIS行SSM术后局部复发的发生率与传统全乳切除术后相似。如有可能,应再次切除切缘接近的组织,并考虑辅助放疗。

相似文献

1
Local recurrence of ductal carcinoma in situ after skin-sparing mastectomy.保留皮肤乳房切除术后导管原位癌的局部复发
J Am Coll Surg. 2007 May;204(5):1074-8; discussion 1078-80. doi: 10.1016/j.jamcollsurg.2007.01.063.
2
Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.导管原位癌治疗后局部复发的预测因素:一项荟萃分析。
Cancer. 1999 Feb 1;85(3):616-28.
3
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.应用USC/范纽斯预后指数的259例乳腺导管原位癌患者:长期随访的回顾性研究
Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9.
4
Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy.接受乳腺癌保乳手术的女性术中手术切缘状态大体检查的准确性。
Am Surg. 2005 Jan;71(1):22-7; discussion 27-8.
5
Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.微浸润性乳腺癌:单机构经验的临床病理分析
Cancer. 2000 Mar 15;88(6):1403-9.
6
Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma.保留皮肤的乳房切除术及即刻乳房重建术是高危乳腺癌患者可接受的一种治疗选择。
Cancer. 2005 Mar 1;103(5):906-13. doi: 10.1002/cncr.20851.
7
Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.导管原位癌。保乳治疗的成功:两项单机构非随机前瞻性研究的共同经验。
Surg Oncol Clin N Am. 1997 Apr;6(2):385-92.
8
Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?前哨淋巴结微转移能否预测导管原位癌及伴微浸润导管原位癌的复发风险?
Am J Surg. 2008 Oct;196(4):566-8. doi: 10.1016/j.amjsurg.2008.06.011. Epub 2008 Aug 29.
9
Influence of local treatment on the recurrence rate of ductal carcinoma in situ.局部治疗对导管原位癌复发率的影响。
J Am Coll Surg. 1995 Jun;180(6):683-8.
10
Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.保留乳头的乳房切除术联合术中放疗(ELIOT):一种用于乳腺癌治疗的新型乳房切除术。
Breast Cancer Res Treat. 2006 Mar;96(1):47-51. doi: 10.1007/s10549-005-9033-7. Epub 2005 Oct 27.

引用本文的文献

1
Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study.保乳手术、乳腺切除术和单纯乳房切除术治疗导管原位癌患者的局部区域复发风险比较:一项单中心研究。
Breast Cancer. 2024 Nov;31(6):1010-1017. doi: 10.1007/s12282-024-01613-2. Epub 2024 Jul 17.
2
Skin-sparing mastectomy for the treatment of breast cancer.保留皮肤的乳腺癌乳房切除术。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD010993. doi: 10.1002/14651858.CD010993.pub2.
3
Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ.
在一个现代、前瞻性的年轻女性导管原位癌患者队列中,临床病理特征、治疗模式和疾病结局。
Ann Surg Oncol. 2022 Dec;29(13):8048-8057. doi: 10.1245/s10434-022-12361-y. Epub 2022 Aug 12.
4
The Senologic International Society Survey on Ductal Carcinoma : Present and Future.国际乳腺病学会导管癌调查:现状与未来
Eur J Breast Health. 2022 Jul 1;18(3):205-221. doi: 10.4274/ejbh.galenos.2022.2022-4-3. eCollection 2022 Jul.
5
Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.年龄对伴或不伴微浸润的导管原位癌行乳房切除术患者的局部区域和远处复发的影响。
Ann Surg Oncol. 2019 Dec;26(13):4264-4271. doi: 10.1245/s10434-019-07693-1. Epub 2019 Aug 22.
6
Prophylactic mastectomy for the prevention of breast cancer: Review of the literature.预防性乳房切除术预防乳腺癌:文献综述
Avicenna J Med. 2018 Jul-Sep;8(3):67-77. doi: 10.4103/ajm.AJM_21_18.
7
Comparison of Local Recurrence After Simple and Skin-Sparing Mastectomy Performed in Patients with Ductal Carcinoma In Situ.导管原位癌患者行单纯乳房切除术与保乳乳房切除术后局部复发情况的比较。
Ann Surg Oncol. 2017 Apr;24(4):1071-1076. doi: 10.1245/s10434-016-5673-6. Epub 2016 Nov 11.
8
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.导管原位癌治疗后同侧和对侧浸润性乳腺癌的后续风险:10,090名女性人群队列中的发病率及放疗效果
Breast Cancer Res Treat. 2016 Oct;159(3):553-63. doi: 10.1007/s10549-016-3973-y. Epub 2016 Sep 8.
9
Nipple areola complex sparing mastectomy.保留乳头乳晕复合体的乳房切除术
Gland Surg. 2015 Dec;4(6):528-40. doi: 10.3978/j.issn.2227-684X.2015.04.12.
10
What is the evidence behind conservative mastectomies?保乳手术背后的证据是什么?
Gland Surg. 2015 Dec;4(6):506-18. doi: 10.3978/j.issn.2227-684X.2015.04.19.